Italy Implantable Cardiac Rhythm Management (crm) Devices Market Size & Outlook
Italy implantable cardiac rhythm management (crm) devices market, 2018-2030 (US$M)
Related Markets
Italy implantable cardiac rhythm management (crm) devices market highlights
- The Italy implantable cardiac rhythm management (crm) devices market generated a revenue of USD 387.4 million in 2023 and is expected to reach USD 611.7 million by 2030.
- The Italy market is expected to grow at a CAGR of 6.7% from 2024 to 2030.
- In terms of segment, cardiac resynchronization therapy (crt) was the largest revenue generating product in 2023.
- Implantable Cardioverter Defibrillators (ICDs) is the most lucrative product segment registering the fastest growth during the forecast period.
Implantable cardiac rhythm management (crm) devices market data book summary
| Market revenue in 2023 | USD 387.4 million |
| Market revenue in 2030 | USD 611.7 million |
| Growth rate | 6.7% (CAGR from 2023 to 2030) |
| Largest segment | Cardiac resynchronization therapy (crt) |
| Fastest growing segment | Implantable Cardioverter Defibrillators (ICDs) |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Cardiac Resynchronization Therapy (CRT), Implantable Cardioverter Defibrillators (ICDs), Pacemakers |
| Key market players worldwide | Stryker Corp, SCHILLER, Medtronic PLC, Abbott Laboratories, Boston Scientific Corp, Koninklijke Philips NV, ZOLL Medical Corporation, BIOTRONIK, Nihon Kohden Corp, MicroPort Scientific Corp |
Other key industry trends
- In terms of revenue, Italy accounted for 3.8% of the global implantable cardiac rhythm management (crm) devices market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany implantable cardiac rhythm management (crm) devices market is projected to lead the regional market in terms of revenue in 2030.
- Spain is the fastest growing regional market in Europe and is projected to reach USD 453.6 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Implantable Cardiac Rhythm Management (CRM) devices market Scope
Implantable Cardiac Rhythm Management (CRM) devices market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Italy implantable cardiac rhythm management (crm) devices market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to implantable cardiac rhythm management (crm) devices market will help companies and investors design strategic landscapes.
Cardiac resynchronization therapy (crt) was the largest segment with a revenue share of 42.26% in 2023. Horizon Databook has segmented the Italy implantable cardiac rhythm management (crm) devices market based on cardiac resynchronization therapy (crt), implantable cardioverter defibrillators (icds), pacemakers covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Italy implantable cardiac rhythm management (crm) devices market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Italy implantable cardiac rhythm management (crm) devices market databook
-
Our clientele includes a mix of implantable cardiac rhythm management (crm) devices market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Italy implantable cardiac rhythm management (crm) devices market, including forecasts for subscribers. This country databook contains high-level insights into Italy implantable cardiac rhythm management (crm) devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Italy implantable cardiac rhythm management device market size, by product, 2018-2030 (US$M)
Italy Implantable Cardiac Rhythm Management (CRM) devices market Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
